feder food and drug administr said approv for market drug reduc bleed hemophiliac requir dental work fda said drug tranemax acid would lessen and some case elimin altogeth for blood transfus hemophiliac must have teeth extract drug will made kabivitrum stockholm sweden and distribut under trade name cyklokapron kabivitrum inc alameda calif hemophilia hereditari diseeas whose victim lack particular protein promot blood clot reuter 